The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Engler, Jonathan Harry Winston
    Company Director born in January 1965
    Individual (5 offsprings)
    Officer
    2011-06-30 ~ now
    OF - Director → CIF 0
  • 2
    Griffiths, Gareth Joseph, Dr
    Research Scientist born in September 1970
    Individual (2 offsprings)
    Officer
    2007-09-17 ~ now
    OF - Director → CIF 0
  • 3
    Rotherham, Neil Eric, Dr
    Company Director born in May 1962
    Individual (6 offsprings)
    Officer
    2017-04-07 ~ now
    OF - Director → CIF 0
  • 4
    Grundy, Nicola Helen
    Director born in December 1966
    Individual (4 offsprings)
    Officer
    2022-07-06 ~ now
    OF - Director → CIF 0
Ceased 8
  • 1
    Mr Jonathan Harry Winston Engler
    Born in January 1965
    Individual (5 offsprings)
    Person with significant control
    2016-04-06 ~ 2017-03-14
    PE - Has significant influence or control → CIF 0
  • 2
    Benson, Roderick Simon Patrick, Dr
    Research Scientist born in September 1966
    Individual (1 offspring)
    Officer
    2007-09-17 ~ 2018-03-12
    OF - Director → CIF 0
    Benson, Roderick Simon Patrick, Dr
    Individual (1 offspring)
    Officer
    2007-09-17 ~ 2017-06-22
    OF - Secretary → CIF 0
  • 3
    Muckle, Geoff
    Pharmaceutical Executive born in May 1977
    Individual (2 offsprings)
    Officer
    2018-09-01 ~ 2022-12-20
    OF - Director → CIF 0
  • 4
    Bristow, James Terence
    Director born in February 1952
    Individual (4 offsprings)
    Officer
    2011-04-15 ~ 2015-05-12
    OF - Director → CIF 0
  • 5
    Kent, Steve James
    Company Director born in March 1962
    Individual (5 offsprings)
    Officer
    2015-05-12 ~ 2022-07-06
    OF - Director → CIF 0
  • 6
    Kerman, Keith Michael
    Director born in April 1958
    Individual
    Officer
    2022-08-04 ~ 2023-03-02
    OF - Director → CIF 0
  • 7
    Noakes, Christopher James
    Director born in August 1984
    Individual
    Officer
    2023-01-18 ~ 2023-02-02
    OF - Director → CIF 0
  • 8
    Goldstein, Richard Brian
    Company Director born in October 1961
    Individual (7 offsprings)
    Officer
    2013-09-16 ~ 2023-01-23
    OF - Director → CIF 0
parent relation
Company in focus

IMAGEN THERAPEUTICS LIMITED

Previous name
IMAGEN BIOTECH LIMITED - 2015-12-22
Standard Industrial Classification
74909 - Other Professional, Scientific And Technical Activities N.e.c.
Brief company account
Property, Plant & Equipment
342,213 GBP2021-12-31
217,779 GBP2020-09-30
Total Inventories
35,185 GBP2021-12-31
80,427 GBP2020-09-30
Debtors
428,682 GBP2021-12-31
150,937 GBP2020-09-30
Cash at bank and in hand
3,503,659 GBP2021-12-31
729,695 GBP2020-09-30
Current Assets
3,967,526 GBP2021-12-31
961,059 GBP2020-09-30
Net Current Assets/Liabilities
3,376,104 GBP2021-12-31
895,511 GBP2020-09-30
Total Assets Less Current Liabilities
3,718,317 GBP2021-12-31
1,113,290 GBP2020-09-30
Creditors
Non-current, Amounts falling due after one year
-6,495 GBP2021-12-31
Net Assets/Liabilities
3,711,822 GBP2021-12-31
1,113,290 GBP2020-09-30
Average Number of Employees
172020-10-01 ~ 2021-12-31
92019-10-01 ~ 2020-09-30
Property, Plant & Equipment - Gross Cost
Tools/Equipment for furniture and fittings
171,496 GBP2021-12-31
99,183 GBP2020-09-30
Other
584,901 GBP2021-12-31
547,423 GBP2020-09-30
Property, Plant & Equipment - Gross Cost
854,856 GBP2021-12-31
646,606 GBP2020-09-30
Land and buildings
98,459 GBP2021-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Tools/Equipment for furniture and fittings
87,353 GBP2021-12-31
70,859 GBP2020-09-30
Other
425,290 GBP2021-12-31
362,143 GBP2020-09-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
512,643 GBP2021-12-31
433,002 GBP2020-09-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Tools/Equipment for furniture and fittings
16,494 GBP2020-10-01 ~ 2021-12-31
Other
63,147 GBP2020-10-01 ~ 2021-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
79,641 GBP2020-10-01 ~ 2021-12-31
Property, Plant & Equipment
Land and buildings
98,459 GBP2021-12-31
Tools/Equipment for furniture and fittings
84,143 GBP2021-12-31
28,324 GBP2020-09-30
Other
159,611 GBP2021-12-31
189,455 GBP2020-09-30
Other types of inventories not specified separately
35,185 GBP2021-12-31
80,427 GBP2020-09-30
Trade Debtors/Trade Receivables
89,397 GBP2021-12-31
54,113 GBP2020-09-30
Prepayments
126,893 GBP2021-12-31
59,446 GBP2020-09-30
Other Debtors
212,392 GBP2021-12-31
37,378 GBP2020-09-30
Debtors
Current
428,682 GBP2021-12-31
150,937 GBP2020-09-30
Total Borrowings
Current, Amounts falling due within one year
1,798 GBP2021-12-31
Trade Creditors/Trade Payables
231,357 GBP2021-12-31
35,618 GBP2020-09-30
Taxation/Social Security Payable
31,542 GBP2021-12-31
18,140 GBP2020-09-30
Accrued Liabilities
321,915 GBP2021-12-31
9,699 GBP2020-09-30
Other Creditors
4,810 GBP2021-12-31
2,091 GBP2020-09-30
Total Borrowings
Non-current, Amounts falling due after one year
6,495 GBP2021-12-31
Par Value of Share
Class 1 ordinary share
0.0012020-10-01 ~ 2021-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
2,059,664 shares2021-12-31
1,586,784 shares2020-09-30
Par Value of Share
Class 2 ordinary share
0.0012020-10-01 ~ 2021-12-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
19,200 shares2021-12-31
19,200 shares2020-09-30
Par Value of Share
Class 3 ordinary share
0.0012020-10-01 ~ 2021-12-31
Number of Shares Issued (Fully Paid)
Class 3 ordinary share
67,500 shares2021-12-31
67,500 shares2020-09-30
Par Value of Share
Class 4 ordinary share
0.0012020-10-01 ~ 2021-12-31
Number of Shares Issued (Fully Paid)
Class 4 ordinary share
5,000 shares2021-12-31
5,000 shares2020-09-30
Number of Shares Issued (Fully Paid)
2,151,364 shares2021-12-31
1,678,484 shares2020-09-30
Nominal value of allotted share capital
2,151 GBP2020-10-01 ~ 2021-12-31
1,678 GBP2019-10-01 ~ 2020-09-30
Bank Borrowings
Non-current
6,495 GBP2021-12-31
Current
1,798 GBP2021-12-31
  • IMAGEN THERAPEUTICS LIMITED
    Info
    IMAGEN BIOTECH LIMITED - 2015-12-22
    Registered number 06373341
    Pearl Assurance House, 319 Ballards Lane, London N12 8LY
    Private Limited Company incorporated on 2007-09-17 (17 years 9 months). The company status is Liquidation.
    The last date of confirmation statement was made at 2022-09-17
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.